NPR logo The Motley Fool Take

The Motley Fool Take

Good medicine for Johnson & Johnson, X doesn't mark the spot for Microsoft, and the housewarming may be over for the housing market. Tom and David Gardner give the Motley Fool Take on some of the week's big business stories, and a few other stories that showed up on the Fool radar.